Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2004 3
2005 2
2006 6
2007 2
2008 4
2009 1
2010 4
2011 5
2012 4
2013 6
2014 6
2015 5
2016 3
2017 9
2018 3
2019 8
2020 8
2021 2
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Control of Metastasis by NK Cells.
López-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. López-Soto A, et al. Among authors: gonzalez s. Cancer Cell. 2017 Aug 14;32(2):135-154. doi: 10.1016/j.ccell.2017.06.009. Cancer Cell. 2017. PMID: 28810142 Free article. Review.
Immunosurveillance of cancer cell stress.
Lorenzo-Herrero S, Sordo-Bahamonde C, González S, López-Soto A. Lorenzo-Herrero S, et al. Among authors: gonzalez s. Cell Stress. 2019 Jul 3;3(9):295-309. doi: 10.15698/cst2019.09.198. Cell Stress. 2019. PMID: 31535086 Free PMC article. Review.
The Emerging Role of NK Cells in Immune Checkpoint Blockade.
Martinez-Perez A, Aguilar-Garcia C, Gonzalez S. Martinez-Perez A, et al. Among authors: gonzalez s. Cancers (Basel). 2022 Dec 6;14(23):6005. doi: 10.3390/cancers14236005. Cancers (Basel). 2022. PMID: 36497486 Free PMC article.
NK Cell-Based Immunotherapy in Cancer Metastasis.
Lorenzo-Herrero S, López-Soto A, Sordo-Bahamonde C, Gonzalez-Rodriguez AP, Vitale M, Gonzalez S. Lorenzo-Herrero S, et al. Among authors: gonzalez s. Cancers (Basel). 2018 Dec 28;11(1):29. doi: 10.3390/cancers11010029. Cancers (Basel). 2018. PMID: 30597841 Free PMC article. Review.
NKG2D signaling in cancer immunosurveillance.
López-Soto A, Huergo-Zapico L, Acebes-Huerta A, Villa-Alvarez M, Gonzalez S. López-Soto A, et al. Among authors: gonzalez s. Int J Cancer. 2015 Apr 15;136(8):1741-50. doi: 10.1002/ijc.28775. Epub 2014 Mar 3. Int J Cancer. 2015. PMID: 24615398 Free article. Review.
Chemo-Immunotherapy: A New Trend in Cancer Treatment.
Sordo-Bahamonde C, Lorenzo-Herrero S, Gonzalez-Rodriguez AP, Martínez-Pérez A, Rodrigo JP, García-Pedrero JM, Gonzalez S. Sordo-Bahamonde C, et al. Among authors: gonzalez s. Cancers (Basel). 2023 May 25;15(11):2912. doi: 10.3390/cancers15112912. Cancers (Basel). 2023. PMID: 37296876 Free PMC article. Review.
Mechanisms of Resistance to NK Cell Immunotherapy.
Sordo-Bahamonde C, Vitale M, Lorenzo-Herrero S, López-Soto A, Gonzalez S. Sordo-Bahamonde C, et al. Among authors: gonzalez s. Cancers (Basel). 2020 Apr 7;12(4):893. doi: 10.3390/cancers12040893. Cancers (Basel). 2020. PMID: 32272610 Free PMC article. Review.
Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade.
López-Soto A, Gonzalez S, Galluzzi L. López-Soto A, et al. Among authors: gonzalez s. Oncoimmunology. 2017 Jul 13;6(10):e1346766. doi: 10.1080/2162402X.2017.1346766. eCollection 2017. Oncoimmunology. 2017. PMID: 29123961 Free PMC article. No abstract available.
90 results